Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA 98109, USA; Department of Biochemistry, University of Washington, School of Medicine, Seattle, WA 98195, USA.
Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, School of Medicine, Seattle, WA 98105, USA.
Cell Rep. 2022 Mar 1;38(9):110457. doi: 10.1016/j.celrep.2022.110457.
Bifurcation of cellular fates, a critical process in development, requires histone 3 lysine 27 methylation (H3K27me3) marks propagated by the polycomb repressive complex 2 (PRC2). However, precise chromatin loci of functional H3K27me3 marks are not yet known. Here, we identify critical PRC2 functional sites at high resolution. We fused a computationally designed protein, EED binder (EB), which competes with EZH2 and thereby inhibits PRC2 function, to dCas9 (EBdCas9) to allow for PRC2 inhibition at a precise locus using gRNA. Targeting EBdCas9 to four different genes (TBX18, p16, CDX2, and GATA3) results in precise H3K27me3 and EZH2 reduction, gene activation, and functional outcomes in the cell cycle (p16) or trophoblast transdifferentiation (CDX2 and GATA3). In the case of TBX18, we identify a PRC2-controlled, functional TATA box >500 bp upstream of the TBX18 transcription start site (TSS) using EBdCas9. Deletion of this TATA box eliminates EBdCas9-dependent TATA binding protein (TBP) recruitment and transcriptional activation. EBdCas9 technology may provide a broadly applicable tool for epigenomic control of gene regulation.
细胞命运的分支是发育过程中的一个关键过程,需要组蛋白 3 赖氨酸 27 甲基化(H3K27me3)标记通过多梳抑制复合物 2(PRC2)传播。然而,功能 H3K27me3 标记的确切染色质位置尚不清楚。在这里,我们以高分辨率确定了关键的 PRC2 功能位点。我们将一种经过计算设计的蛋白质,EED 结合蛋白(EB),与 EZH2 竞争,从而抑制 PRC2 功能,融合到 dCas9 上(EBdCas9),以便使用 gRNA 在精确的基因座上抑制 PRC2。将 EBdCas9 靶向四个不同的基因(TBX18、p16、CDX2 和 GATA3)导致精确的 H3K27me3 和 EZH2 减少、基因激活以及细胞周期(p16)或滋养层转分化(CDX2 和 GATA3)中的功能结果。在 TBX18 的情况下,我们使用 EBdCas9 鉴定了 PRC2 控制的、功能性 TATA 盒>500 bp 上游的 TBX18 转录起始位点(TSS)。删除这个 TATA 盒消除了 EBdCas9 依赖性 TATA 结合蛋白(TBP)募集和转录激活。EBdCas9 技术可能为基因调控的表观基因组控制提供一种广泛适用的工具。